XTL Biopharmaceuticals Ltd. Gains 46.43%
Wed, Oct 08, 2025 at 07:54 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) rocketted at $2.05, representing a gain of 46.4%. On Wed, Oct 08, 2025, XTLB:NASDAQ hit a New 2-Week High of $2.05. From Wed, Sep 24, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 08, 2025 at $2.57 with a volume of 34M+.
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 141.49%
- Nexalin Technology, Inc. (NXL:NASDAQ), 98.25%
- AlphaTON Capital Corp Shs (New) (ATON:NASDAQ), 95.52%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 89.25%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 82.98%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 51.88%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 46.43%
- TNL Mediagene (TNMG:NASDAQ), 45.5%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 39.41%